Interleukin-17A Gene Variability in Patients with Type 1 Diabetes Mellitus and Chronic Periodontitis: Its Correlation with IL-17 Levels and the Occurrence of Periodontopathic Bacteria
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26924897
PubMed Central
PMC4748108
DOI
10.1155/2016/2979846
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- chronická parodontitida krev genetika mikrobiologie MeSH
- diabetes mellitus 1. typu krev genetika MeSH
- dospělí MeSH
- frekvence genu genetika MeSH
- genotyp MeSH
- interleukin-17 krev genetika MeSH
- jednonukleotidový polymorfismus genetika MeSH
- leukocyty mononukleární metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- IL17A protein, human MeSH Prohlížeč
- IL17F protein, human MeSH Prohlížeč
- interleukin-17 MeSH
Interleukin-17 contributes to the pathogenesis of type 1 diabetes mellitus (T1DM) and chronic periodontitis (CP). We analyzed IL-17A -197A/G and IL-17F +7488C/T polymorphisms in T1DM and CP and determined their associations with IL-17 production and occurrence of periopathogens. Totally 154 controls, 125 T1DM, and 244 CP patients were genotyped using 5' nuclease TaqMan(®) assays. Bacterial colonization was investigated by a DNA-microarray kit. Production of IL-17 after in vitro stimulation of mononuclear cells by mitogens and bacteria was examined by the Luminex system. Although no differences in the allele/genotype frequencies between patients with CP and T1DM + CP were found, the IL-17A -197 A allele increased the risk of T1DM (P < 0.05). Levels of HbA1c were significantly elevated in carriers of the A allele in T1DM patients (P < 0.05). Production of IL-17 by mononuclear cells of CP patients (unstimulated/stimulated by Porphyromonas gingivalis) was associated with IL-17A A allele (P < 0.05). IL-17A polymorphism increased the number of Tannerella forsythia and Treponema denticola in patients with CP and T1DM + CP, respectively (P < 0.05). IL-17A gene variability may influence control of T1DM and the "red complex" bacteria occurrence in patients with CP and T1DM + CP. Our findings demonstrated the functional relevance of the IL-17A polymorphism with higher IL-17 secretion in individuals with A allele.
Zobrazit více v PubMed
Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329–334. doi: 10.2337/diacare.16.1.329. PubMed DOI
Mealey B. L. Periodontal disease and diabetes. A two-way street. Journal of the American Dental Association. 2006;137(supplement):26S–31S. PubMed
Sima C., Rhourida K., Van Dyke T. E., Gyurko R. Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo . Journal of Periodontal Research. 2010;45(6):748–756. doi: 10.1111/j.1600-0765.2010.01295.x. PubMed DOI PMC
Silvestre F.-J., Miralles L., Llambes F., Bautista D., Solá-Izquierdo E., Hernández-Mijares A. Type 1 diabetes mellitus and periodontal disease: relationship to different clinical variables. Medicina Oral, Patologia Oral y Cirugia Bucal. 2009;14(4):E175–E179. PubMed
Sakalauskiene J., Kubilius R., Gleiznys A., Vitkauskiene A., Ivanauskiene E., Šaferis V. Relationship of clinical and microbiological variables in patients with type 1 diabetes mellitus and periodontitis. Medical Science Monitor. 2014;20:1871–1877. doi: 10.12659/msm.890879. PubMed DOI PMC
Bedoya S. K., Lam B., Lau K., Larkin J., III Th17 cells in immunity and autoimmunity. Clinical and Developmental Immunology. 2013;2013:16. doi: 10.1155/2013/986789.986789 PubMed DOI PMC
Marwaha A. K., Tan S., Dutz J. P. Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetes. Clinical Immunology. 2014;154(1):84–89. doi: 10.1016/j.clim.2014.06.006. PubMed DOI
Kumar P., Subramaniyam G. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Cytokine. 2015;71(2):366–376. doi: 10.1016/j.cyto.2014.10.010. PubMed DOI
Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunological Reviews. 2008;226(1):57–79. doi: 10.1111/j.1600-065X.2008.00699.x. PubMed DOI
Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149–162. doi: 10.1016/j.immuni.2011.02.012. PubMed DOI
Boroń D., Agnieszka S., Daniel K., Anna B., Adam K. Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women. European Journal of Medical Research. 2014;19(1, article 69) doi: 10.1186/s40001-014-0069-1. PubMed DOI PMC
Bradshaw E. M., Raddassi K., Elyaman W., et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. The Journal of Immunology. 2009;183(7):4432–4439. doi: 10.4049/jimmunol.0900576. PubMed DOI PMC
Arif S., Moore F., Marks K., et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes. 2011;60(8):2112–2119. doi: 10.2337/db10-1643. PubMed DOI PMC
Kumar P., Natarajan K., Shanmugam N. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression. Cellular Signalling. 2014;26(3):528–539. doi: 10.1016/j.cellsig.2013.11.031. PubMed DOI
Zenobia C., Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontology 2000. 2015;69(1):142–159. doi: 10.1111/prd.12083. PubMed DOI PMC
Mitani A., Niedbala W., Fujimura T., et al. Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. Journal of Periodontology. 2015;86(2):301–309. doi: 10.1902/jop.2014.140293. PubMed DOI
Shaker O. G., Ghallab N. A. IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection. Mediators of Inflammation. 2012;2012:7. doi: 10.1155/2012/174764.174764 PubMed DOI PMC
Behfarnia P., Birang R., Pishva S. S., et al. Expression levels of th-2 and th-17 characteristic genes in healthy tissue versus periodontitis. Journal of Dentistry (Tehran, Iran) 2013;10(1):23–31. PubMed PMC
Wang H., Luo Z., Lei L., et al. Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation. 2013;36(3):696–704. doi: 10.1007/s10753-013-9594-2. PubMed DOI
Awang R. A., Lappin D. F., MacPherson A., et al. Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity. Inflammation Research. 2014;63(12):1001–1012. doi: 10.1007/s00011-014-0776-7. PubMed DOI
Luo Z., Wang H., Wu Y., Sun Z., Wu Y. Clinical significance of IL-23 regulating IL-17A and/or IL-17F positive Th17 cells in chronic periodontitis. Mediators of Inflammation. 2014;2014:9. doi: 10.1155/2014/627959.627959 PubMed DOI PMC
Chitrapriya M., Rao S. R., Lavu V. Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease. Journal of Indian Society of Periodontology. 2015;19(1):14–17. doi: 10.4103/0972-124x.145798. PubMed DOI PMC
Yu J. J., Ruddy M. J., Wong G. C., et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007;109(9):3794–3802. doi: 10.1182/blood-2005-09-010116. PubMed DOI PMC
Yu J. J., Ruddy M. J., Conti H. R., Boonanantanasarn K., Gaffen S. L. The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infection and Immunity. 2008;76(9):4206–4213. doi: 10.1128/iai.01209-07. PubMed DOI PMC
Johnson R. B., Wood N., Serio F. G. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. Journal of Periodontology. 2004;75(1):37–43. doi: 10.1902/jop.2004.75.1.37. PubMed DOI
Takahashi K., Azuma T., Motohira H., Kinane D. F., Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. Journal of Clinical Periodontology. 2005;32(4):369–374. doi: 10.1111/j.1600-051X.2005.00676.x. PubMed DOI
Vernal R., Dutzan N., Chaparro A., Puente J., Valenzuela M. A., Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. Journal of Clinical Periodontology. 2005;32(4):383–389. doi: 10.1111/j.1600-051x.2005.00684.x. PubMed DOI
Park Y.-D., Kim Y.-S., Jung Y.-M., et al. Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells. Cytokine. 2012;60(1):284–293. doi: 10.1016/j.cyto.2012.05.021. PubMed DOI
Kadkhodazadeh M., Baghani Z., Ebadian A. R., Youssefi N., Mehdizadeh A. R., Azimi N. IL-17 gene polymorphism is associated with chronic periodontitis and peri-implantitis in Iranian patients: a cross-sectional study. Immunological Investigations. 2013;42(2):156–163. doi: 10.3109/08820139.2012.746697. PubMed DOI
Kadkhodazadeh M., Ebadian A. R., Amid R., Youssefi N., Mehdizadeh A. R. Interleukin 17 receptor gene polymorphism in periimplantitis and chronic periodontitis. Acta Medica Iranica. 2013;51(6):353–358. PubMed
Corrêa J. D., Madeira M. F., Resende R. G., et al. Association between polymorphisms in interleukin-17A and -17F genes and chronic periodontal disease. Mediators of Inflammation. 2012;2012:9. doi: 10.1155/2012/846052.846052 PubMed DOI PMC
Saraiva A. M., Alves e Silva M. R. M., Correia Silva J. D. F., et al. Evaluation of IL17A expression and of IL17A, IL17F and IL23R gene polymorphisms in Brazilian individuals with periodontitis. Human Immunology. 2013;74(2):207–214. doi: 10.1016/j.humimm.2012.10.026. PubMed DOI
Zacarias J. M., Sippert E. Â., Tsuneto P. Y., Visentainer J. E., Silva C. d., Sell A. M. The Influence of interleukin 17A and IL17F polymorphisms on chronic periodontitis disease in Brazilian patients. Mediators of Inflammation. 2015;2015:8. doi: 10.1155/2015/147056.147056 PubMed DOI PMC
Pácal L., Varvařovská J., Rušavý Z., et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Archives of Physiology and Biochemistry. 2011;117(4):222–230. doi: 10.3109/13813455.2010.551135. PubMed DOI
Borilova Linhartova P., Vokurka J., Poskerova H., Fassmann A., Izakovicova Holla L. Haplotype analysis of interleukin-8 gene polymorphisms in chronic and aggressive periodontitis. Mediators of Inflammation. 2013;2013:8. doi: 10.1155/2013/342351.342351 PubMed DOI PMC
Bártová J., Bořilová Linhartová P., Podzimek S., et al. The effect of IL-4 gene polymorphisms on cytokine production in patients with chronic periodontitis and in healthy controls. Mediators of Inflammation. 2014;2014:11. doi: 10.1155/2014/185757.185757 PubMed DOI PMC
Roohi A., Tabrizi M., Abbasi F., et al. Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls. BioMed Research International. 2014;2014:7. doi: 10.1155/2014/718946.718946 PubMed DOI PMC
Eskan M. A., Jotwani R., Abe T., et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunology. 2012;13(5):465–473. doi: 10.1038/ni.2260. PubMed DOI PMC
Khader S. A. Restraining IL-17: Del-1 deals the blow. Nature Immunology. 2012;13(5):433–435. doi: 10.1038/ni.2290. PubMed DOI
Takahashi S., Fukuda M., Mitani A., et al. Follicular dendritic cell-secreted protein is decreased in experimental periodontitis concurrently with the increase of interleukin-17 expression and the Rankl/Opg mRNA ratio. Journal of Periodontal Research. 2014;49(3):390–397. doi: 10.1111/jre.12118. PubMed DOI
Cheng W.-C., Hughes F. J., Taams L. S. The presence, function and regulation of IL-17 and Th17 cells in periodontitis. Journal of Clinical Periodontology. 2014;41(6):541–549. doi: 10.1111/jcpe.12238. PubMed DOI
Nordang G. B. N., Viken M. K., Hollis-Moffatt J. E., et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology. 2009;48(4):367–370. doi: 10.1093/rheumatology/ken512. PubMed DOI
Espinoza J. L., Takami A., Nakata K., et al. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS ONE. 2011;6(10) doi: 10.1371/journal.pone.0026229.e26229 PubMed DOI PMC
Liu X. K., Lin X., Gaffen S. L. Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. The Journal of Biological Chemistry. 2004;279(50):52762–52771. doi: 10.1074/jbc.m405764200. PubMed DOI
Shao S., He F., Yang Y., Yuan G., Zhang M., Yu X. Th17 cells in type 1 diabetes. Cellular Immunology. 2012;280(1):16–21. doi: 10.1016/j.cellimm.2012.11.001. PubMed DOI
Ururahy M. A. G., de Souza K. S. C., Oliveira Y. M. D. C., et al. Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio. Diabetes/Metabolism Research and Reviews. 2015;31(5):500–506. doi: 10.1002/dmrr.2621. PubMed DOI
Altinova A. E., Engin D., Akbay E., et al. Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to type 1 diabetes in Turkish patients. Journal of Endocrinological Investigation. 2010;33(7):451–454. doi: 10.3275/6766. PubMed DOI
Hadžija M. P., Korolija M., Jemin N., et al. Polymorphisms in the IL-18 and IL-12B genes and their association with the clinical outcome in Croatian patients with Type 1 diabetes. Gene. 2013;512(2):477–481. doi: 10.1016/j.gene.2012.10.029. PubMed DOI
Gürsoy U. K., Çiftlikli S. Y., Könönen E., Gürsoy M., Doğan B. Salivary interleukin-17 and tumor necrosis factor-α in relation to periodontitis and glycemic status in type 2 diabetes mellitus. Journal of Diabetes. 2015;7(5):681–688. doi: 10.1111/1753-0407.12228. PubMed DOI
Shabgah A. G., Fattahi E., Shahneh F. Z. Interleukin-17 in human inflammatory diseases. Postepy Dermatologii i Alergologii. 2014;31(4):256–261. doi: 10.5114/pdia.2014.40954. PubMed DOI PMC
Finoti L. S., Corbi S. C. T., Anovazzi G., et al. Association between IL8 haplotypes and pathogen levels in chronic periodontitis. European Journal of Clinical Microbiology and Infectious Diseases. 2013;32(10):1333–1340. doi: 10.1007/s10096-013-1884-y. PubMed DOI
Nibali L., Ready D. R., Parkar M., et al. Gene polymorphisms and the prevalence of key periodontal pathogens. Journal of Dental Research. 2007;86(5):416–420. doi: 10.1177/154405910708600505. PubMed DOI
Nibali L., Tonetti M. S., Ready D., et al. Interleukin-6 polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. Journal of Periodontology. 2008;79(4):677–683. doi: 10.1902/jop.2008.070453. PubMed DOI
Nibali L., Donos N., Farrell S., et al. Association between interleukin-6 -174 polymorphism and Aggregatibacter actinomycetemcomitans in chronic periodontitis. Journal of Periodontology. 2010;81(12):1814–1819. doi: 10.1902/jop.2010.100084. PubMed DOI
Nibali L., Madden I., Franch Chillida F., Heitz-Mayfield L. J. A., Brett P. M., Donos N. IL6 -174 genotype associated with Aggregatibacter actinomycetemcomitans in Indians. Oral Diseases. 2011;17(2):232–237. doi: 10.1111/j.1601-0825.2010.01731.x. PubMed DOI
Nibali L., D'Aiuto F., Ready D., Parkar M., Yahaya R., Donos N. No association between A. actinomycetemcomitans or P. gingivalis and chronic or aggressive periodontitis diagnosis. Quintessence International. 2012;43(3):247–254. PubMed
Schulz S., Stein J. M., Altermann W., et al. Single nucleotide polymorphisms in interleukin-1gene cluster and subgingival colonization with Aggregatibacter actinomycetemcomitans in patients with aggressive periodontitis. Human Immunology. 2011;72(10):940–946. doi: 10.1016/j.humimm.2011.05.009. PubMed DOI
Moutsopoulos N. M., Kling H. M., Angelov N., et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. Journal of Autoimmunity. 2012;39(4):294–303. doi: 10.1016/j.jaut.2012.03.003. PubMed DOI PMC
Krishnan V. V., Ravindran R., Wun T., Luciw P. A., Khan I. H., Janatpour K. Multiplexed measurements of immunomodulator levels in peripheral blood of healthy subjects: effects of analytical variables based on anticoagulants, age, and gender. Cytometry Part B: Clinical Cytometry. 2014;86(6):426–435. doi: 10.1002/cyto.b.21147. PubMed DOI
Khan S. S., Smith M. S., Reda D., et al. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B, Clinical Cytometry. 2004;61(1):35–39. PubMed